H1-Receptor Antagonists: Comparative Tolerability and Safety

Drug Safety

Volumn 10, Issue 5, 1994, Pages 350-380

  Simons, F Estelle R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HISTAMINE H1 RECEPTOR ANTAGONIST; ACRIVASTINE; ALIMEMAZINE; ASTEMIZOLE; AZATADINE; AZELASTINE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; CYPROHEPTADINE; DIAZEPAM; DIMENHYDRINATE; DIMETINDENE; DIPHENHYDRAMINE; EBASTINE; ERYTHROMYCIN; HYDROXYZINE; ITRACONAZOLE; KETOCONAZOLE; KETOTIFEN; LEVOCABASTINE; LORATADINE; MEQUITAZINE; PROMETHAZINE; TERFENADINE; TRIPELENNAMINE; TRIPROLIDINE;

ANIMAL; BLOOD BRAIN BARRIER; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONGENITAL MALFORMATION; DRUG EFFECT; DRUG INTERACTION; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; HUMAN; PHARMACOEPIDEMIOLOGY; PSYCHOMOTOR PERFORMANCE; REVIEW; ALLERGIC RHINITIS; ALLERGY; AMNESIA; BRADYCARDIA; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL TRIAL; CONCENTRATION LOSS; CONTACT DERMATITIS; DOSE RESPONSE; DRUG ELIMINATION; DRUG OVERDOSE; DRUG SAFETY; DRUG TRANSFORMATION; ELECTROENCEPHALOGRAM; EXTRASYSTOLE; FETUS DISEASE; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; INSOMNIA; JAUNDICE; MOTION SICKNESS; ORAL DRUG ADMINISTRATION; PARESTHESIA; PREGNANCY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RHINOCONJUNCTIVITIS; SINUS TACHYCARDIA; SOMNOLENCE; TOPICAL DRUG ADMINISTRATION; TREMOR;

ABNORMALITIES, DRUG-INDUCED; ANIMAL; BLOOD-BRAIN BARRIER; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; ETHANOL; HISTAMINE H1 ANTAGONISTS; HUMAN; PHARMACOEPIDEMIOLOGY; PSYCHOMOTOR PERFORMANCE;

EID: 0028173646     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-199410050-00002     Document Type: Review

References (263)

1. The hypnotic effects of an antihistamine: promethazine
2. The effects of loratadine, diphenhydramine and placebo on worker productivity: results of a double blind trial
3. Three month evaluation of electrocardiographic effects of loratadine in humans
4. 3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine
5. A comparison of antihistamines using EEG and questionnaire-based assessments
6. Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study
7. Cyproheptadine and growth
8. Absence of central effects with levocabastine eye drops
9. First-trimester drug use and congenital disorders
10. Effect of terfenadine, a novel antihistamine, on actual driving performance
11. Effect of haemodialysis on the pharmacokinetics of cetirizine
12. Diphenhydramine suicide —case report
13. An unusual case of cyproheptadine (Periactin) overdose in an adolescent female
14. Unusual treatment response of a severe dystonia to diphenhydramine
15. 1
16. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine
17. Lack of effect of astemizole on ethanol dynamics or kinetics
18. The effect of diphenhydramine alone and in combination with ethanol on histamine skin response and mental performance
19. Toxic psychosis due to cyproheptadine in a child on hemodialysis: a case report
20. The effect of single doses of 120 mg and 240 mg of terfenadine on driving and other measures of psychomotor performance including visual evoked responses
21. Effects of two antihistamine drugs on actual driving performance
22. The effects of terfenadine with and without alcohol on an aspect of car driving performance
23. Effects of azatadine maleate on subjective appraisal and psychomotor functions relevant to driving performance
24. Prolonged Q-T interval following astemizole overdose
25. Effect of diphenhydramine on subjective sleep parameters and on motor activity during bedtime
26. Danger with Benadryl of self medication and large dosage
27. 1-antagonist, loratadine
28. Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers
29. Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion
30. 1-histamine receptor antagonist ebastine in 10, 20, and 30 mg dose, and triprolidine 10 mg on car driving performance
31. Effects of diphenhydramine and alcohol on skills performance
32. Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man
33. Effects on the human central nervous system of two isomers of ephedrine and triprolidine, and their interaction
34. Correlation between plasma diphenhydramine level and sedative and antihistamine effects
35. A randomized single-blind study of astemizole and chlorpheniramine in normal volunteers
36. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario
37. Astemizole-induced ventricular arrhythmias: an unexpected cause of convulsions
38. Performance studies with antihistamines
39. The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance
40. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects
41. Contact dermatitis caused by diphenhydramine hydrochloride
42. 1-histamine, antipruritic and sedating effects
43. Torsade de pointes after astemizole overdose
44. Dimenhydrinate dependence and withdrawal
45. Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine
46. Anemia following use of antihistaminic drugs
47. Cardiotoxic effect with convulsions in terfenadine overdose
48. Dyskinesia associated with chronic antihistamine use
49. QT prolongation and sudden cardiac death in patients with alcoholic liver disease
50. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis
51. Chlorpheniramine-induced bone marrow suppression
52. Effects of antihistamines on daytime alertness
53. Effect of astemizole on psychomotor performance in healthy Thais
54. EEG findings following intravenous injection of diphenhydramine hydrochloride (Benadryl)
55. Hallucinations and hyperthermia after promethazine ingestion
56. Lack of potentiation by cetirizine of alcohol-induced psychomotor disturbances
57. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists
58. The I antigen as an immune complex receptor in a case of haemolytic anemia induced by an antihistaminic agent
59. Fixed drug eruption caused by diphenhydramine
60. Effect of cimetidine on terfenadine and terfenadine metabolite pharmacokinetics
61. Pharmacokinetic interaction between terfenadine and ketoconazole
62. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis
63. Facial dyskinesia related to antihistamine?
64. Toxic encephalopathy caused by topically applied diphenhydramine
65. CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918)
66. Prospective study of the electrocardiographic effects of imipramine in children
67. The interaction between ethanol and antihistamines. 2. Clemastine
68. Comparison between alprazolam and hydroxyzine for oral premedication
69. Patient hair loss
70. The use of Benadryl for sleep EEG’s
71. The influence of antihistamines on human performance
72. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine
73. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator
74. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance
75. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review
76. Accidental childhood death from diphenhydramine overdosage
77. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine
78. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine
79. Transport of diphenhydramine in the central nervous system
80. Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects
81. Comparative study of EEG effects of antihistamines in normal volunteers
82. Cyclizine toxicity —intentional drug abuse of a proprietary antihistamine
83. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders
84. Safety of therapy for allergic symptoms during pregnancy
85. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis
86. Activated charcoal adsorption of diphenhydramine
87. 1-receptor antagonists
88. Antihistamine-associated sudden death, ventricular arrhythmias, syncope and QT-interval prolongation: a comparison of terfenadine and other antihistamines
89. Diphenhydramine hydrochloride intoxication
90. 1 antihistamines
91. Should promethazine in liquid form be available without prescription?
92. Effects of altitude and two decongestant-antihistamine preparations on physiological functions and performance
93. Drugs in pregnancy: effects on the fetus and newborn
94. Psychomotor effects of astemizole and chlorpheniramine, alone and in combination with alcohol
95. A placebo-controlled assessment of mequitazine and astemizole in tests of psychomotor ability
96. A repeated dose comparison of the side effects of five antihistamines on objective assessments of psychomotor performance, central nervous system arousal and subjective appraisals of sleep and early morning behaviour
97. Fixed drug eruption due to dimenhydrinate
98. Hydroxyzine hydrochloride: possible adverse cardiac interactions
99. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin
100. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine
101. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences
102. Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters
103. The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans
104. Accidental astemizole overdose in young children
105. Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults
106. Comparative effect of three antihistamines and ethanol on mental and motor performance
107. Diphenhydramine poisoning treated by exchange transfusion
108. Astemizole. A nonsedating antihistamine with fast and sustained activity
109. Diphenhydramine-induced toxic psychosis
110. Urinary frequency in an adolescent female
111. Phenothiazines and sudden infant death syndrome
112. Are over-the-counter sleep medications effective? All night EEG studies
113. Cleft lip repair using intramuscular hydroxyzine sedation and local anesthesia
114. Astemizole-induced paresthesia
115. Controlled clinical investigation of trimeprazine as a sleep-inducer in normal subjects
116. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse
117. Pyribenzamine activation of the electroencephalogram
118. Clinical symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1982 to 1985
119. Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man
120. Massive diphenhydramine overdose resulting in death
121. Haloperidol-induced torsades de pointes
122. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double-blind study
123. Some clinical pharmacological studies with terfenadine, a new antihistamine drug
124. 1 antagonist, astemizole
125. Antihistamines, alone and together with alcohol, in relation to driving safety
126. Prolonged cholestasis after cyproheptadine-induced acute hepatitis
127. Effect of cyproheptadine on asthmatic children
128. Acute dystonia. An unusual reaction to diphenhydramine
129. Acute ketotifen overdosage. A review of present clinical experience
130. Physostigmine reversal of antihistamine-induced excitement and depression
131. Paranoid psychosis after abuse of Actifed
132. Giant U waves and associated ventricular tachycardia complicating astemizole overdose: successful therapy with intravenous magnesium
133. 1-receptor antagonists
134. Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine
135. Dystonic reactions to Dimotapp elixir
136. Asynchronies of diphenhydramine plasma-performance relationships
137. Astemizole-associated urinary retention
138. Effects of antihistamines, chlormezanone and alcohol on psychomotor skills related to driving
139. Torsades de pointes complicating treatment with terfenadine
140. Hydroxyzine intoxication in a 13-month-old child
141. Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines
142. Effects of allergy season on mood and cognitive function
143. Agranulocytosis after antihistaminic therapy
144. Nervous reactions to terfenadine
145. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine
146. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects
147. Dyskinesia associated with amoxapine withdrawal and use of carbamazepine and antihistamines
148. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
149. Differential cognitive effects of terfenadine and chlorpheniramine
150. Doxepin-induced cardiac dysrhythmia
151. Chemically-induced chromosome changes in human cells in vitro
152. Antihistamine-and decongestant-induced performance decrements
153. 1 antihistamines
154. Differences in performance impairment due to brompheniramine maleate as a function of the sustained-release system
155. Effect of promethazine hydrochloride on hand-eye co-ordination
156. Torsades de pointes occurring in association with terfenadine use
157. Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings
158. Antihistaminika und Reaktions-fähigkeit (Antihistamines and reactivity)
159. Effects of terfenadine, diphenhydramine, and placebo on skills performance
160. Evaluation of antihistamine-related daytime sleepiness. A double-blind, placebo-controlled study with terfenadine
161. A double-blind study of the effects of loratadine versus placebo on the performance of pilots
162. Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man
163. 2 antagonists
164. 1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene
165. Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light
166. 1-histamine receptor antagonists, astemizole and terfenadine
167. Antihistamines: impaired performance and the tendency to sleep
168. Immune thrombocytopenia due to antazoline (Antistina)
169. Toxic psychosis due to diphenhydramine hydrochloride
170. Rated performance, cardiovascular and quantitative EEG parameters during simulated instrument flight under the effect of terfenadine
171. Antihistamines and driving performance: the Netherlands
172. Antihistamines and driving safety
173. Probable Benadryl withdrawal manifestations in a newborn infant
174. A comparison of central and peripheral effects of cetirizine and loratadine
175. Comparison of the central and peripheral effects of cetirizine and terfenadine
176. A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness
177. Cognitive and psychomotor evaluation of clemastine-fumarate, diphenhydramine HCl and hydroxyzine HCl: double-blind study
178. Torsades de pointes after terfenadine-itraconazole interaction
179. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride
180. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability
181. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving
182. Breaching the blood-brain barrier
183. + channel cloned from human heart
184. Topically induced diphenhydramine toxicity
185. Chronopharmacological study of antihistamines in man with special references to terfenadine
186. The effects of Benadryl and Hismanal on mood, physiological measures, antihistamine detection, and subjective symptoms
187. Central anticholinergic syndrome in a child: a case report
188. Diphenhydramine in insomniac family practice patients: a doubleblind study
189. The effects of loratadine alone and in combination with alcohol on actual driving performance
190. Survival in complicated diphenhydramine overdose
191. Daytime sleepiness and antihistamines
192. Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo
193. Schizophrenia-like psychosis following ‘Mandrax’ overdose
194. Effects of topical administration of levocabastine on psychomotor and cognitive function
195. 1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine
196. Sedative effects of antihistamines
197. 1-receptor in heart: unique electrophoretic mobility and autoradiographic localization
198. Effects of diphenhydramine in the fetal lamb after maternal or fetal administration
199. The effectiveness of diphenhydramine HCl in pediatric sleep disorders
200. Antimuscarinic activity of terfenadine, chlorpheniramine, atropine and placebo in normal volunteers
201. The toxicity of Benadryl: report of a case and review of the literature
202. Torsades de pointes induced by astemizole in a patient with prolongation of the QT interval
203. Lack of electrocardiographic effects of cetirizine in healthy humans
204. Cardiac effects of acrivastine compared to terfenadine
205. Prolonged QT interval and torsade de pointes following astemizole overdose
206. Cleft palate and maternal diphenhydramine intake
207. The course and management of asthma and allergic diseases during pregnancy
208. An unusual case of antihistamine intoxication
209. Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment
210. Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep
211. Effect of astemizole on human psychomotor performance
212. Poisoning from dermal absorption of promethazine
213. 1-receptor antagonists: clinical pharmacology and therapeutics
214. 1-receptor antagonists: worth the price?
215. Cetirizine, hydroxyzine, and diphenhydramine: studies of central nervous system effects using the P300-event-related potential
216. Astemizole-induced torsade de pointes
217. 1-receptor antagonists) terfenadine and chlorpheniramine in children
218. Antihistamines
219. 1 receptor antagonist hydroxyzine
220. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis
221. 1-receptor antagonist hydroxyzine in the elderly
222. Benadryl, a contributing cause of an accident
223. Torsade de pointes ventricular tachycardia associated with astemizole overdose
224. Receptor effects of cetirizine
225. Terfenadine-induced tremor
226. Antihistamines and highway safety
227. SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis
228. Skin reactions to terfenadine
229. + current by promethazine in guinea-pig ventricular myocytes
230. 1 receptor antagonists for CNS and peripheral receptors? An in vitro study
231. Oral facial dyskinesia associated with prolonged use of antihistaminic decongestants
232. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG
233. Generalised seizure due to terfenadine
234. Generalised seizure due to terfenadine
235. 1-blockers
236. Astemizole-induced cardiac conduction disturbances in a child
237. Diphenhydramine toxicity mimicking varicella encephalitis
238. Ketoconazole inhibits loratadine metabolism in man
239. 1-receptor antagonist ebastine to its active metabolite carebastine
240. A study of the anticholinergic activity of terfenadine in normal volunteers
241. Prolongation of the Q-T interval and hyperkinetic ventricular arrhythmias probably induced by terfenadine use in liver cirrhosis patients
242. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects
243. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness
244. Correlation between EEG changes indicative of sedation and subjective responses
245. Seasonal allergic rhinitis and antihistamine effects on children’s learning
246. Simulated assembly line performance following ingestion of cetirizine or hydroxyzine
247. Drugs detected in fatally injured drivers in the province of Ontario
248. Cardiotoxic effects of astemizole overdose in children
249. Torsade de pointes associated with the use of intravenous haloperidol
250. The effects of phenindamine tartrate on sleepiness and psychomotor performance
251. Topical diphenhydramine toxicity in a five year old with varicella
252. Mechanism of the cardiotoxic actions of terfenadine
253. The toxic effects of antihistaminic drugs
254. Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans
255. Placental transfer of diphenhydramine in chronically instrumented pregnant sheep
256. Dimenhydrinate: evidence for dependence and tolerance
257. Plasma concentrations of astemizole in patients with terminal renal insufficiency, before, during and after hemodialysis
258. 1-antagonist terfenadine
259. Prenatal antihistamine exposure and retrolental fibroplasia
260. Torsades de pointes after treatment with terfenadine and ketoconazole